Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Neostigmine bromide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
|
Product containing neostigmine bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
|
Neostigmine bromide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
1 |
Neostigmine bromide 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
1 |
Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
|
Product containing glycopyrronium bromide and neostigmine bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
|
Neostigmine bromide 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Neostigmine bromide (substance) |
Inferred relationship |
Some |
1 |